Likelihood of mechanistic roles for dopaminergic, serotonergic and glutamatergic receptors in tardive dyskinesia: A comparison of genetic variants in two independent patient populations
Open Access
- 1 January 2016
- journal article
- Published by SAGE Publications in Sage Open Medicine
- Vol. 4
Abstract
Objectives: An established theory for the pathogenesis of tardive dyskinesia is disturbed dopaminergic receptor sensitivity and/or dopaminergic intracellular signaling. We examined associations between genetic variants of neurotransmitter receptors and tardive dyskinesia.Methods: We assessed tardive dyskinesia in Caucasian psychiatric inpatients from Siberia (N = 431) and a long-stay population from the Netherlands (N = 168). These patients were genotyped for 43 tag single nucleotide polymorphisms in five neurotransmitter receptor genes, and the results for the two populations were compared.Results: Several significant associations with tardive dyskinesia were identified, but only GRIN2A (rs1345423) was found in both patient populations. This lack of agreement was probably due to the small effect size of the associations, the multiple testing and the small sample size of the Dutch patient population. After reviewing the literature, we propose that the constitutive stimulatory activity of serotonergic type 2 receptors may be relevant.Conclusions: Inactivity of the serotonergic, type 2C receptor or blockade of these receptors by atypical antipsychotic drugs may decrease the vulnerability to develop tardive dyskinesia.Keywords
This publication has 49 references indexed in Scilit:
- Antipsychotic-Induced Movement Disorders in Long-Stay Psychiatric Patients and 45 Tag SNPs in 7 Candidate Genes: A Prospective StudyPLOS ONE, 2012
- NMDA receptor genotypes associated with the vulnerability to develop dyskinesiaTranslational Psychiatry, 2012
- Pharmacogenetics of Response to Antipsychotics in Patients with SchizophreniaCNS Drugs, 2011
- Antipsychotic Dose Equivalents and Dose-Years: A Standardized Method for Comparing Exposure to Different DrugsBiological Psychiatry, 2010
- The DRD3 rs6280 polymorphism and prevalence of tardive dyskinesia: A meta‐analysisAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2009
- The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common PathwaySchizophrenia Bulletin, 2009
- Association study of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patientsThe Pharmacogenomics Journal, 2009
- Dyskinesia and Parkinsonism in Antipsychotic-Naive Patients With Schizophrenia, First-Degree Relatives and Healthy Controls: A Meta-analysisSchizophrenia Bulletin, 2008
- Tardive dyskinesia and DRD2, DRD3, DRD4, 5-HT2A variants in schizophrenia: an association study with repeated assessmentInternational Journal of Neuropsychopharmacology, 1999
- Proposed Schizophrenia-Related Gene Polymorphism: Expression of the Ser9Gly Mutant Human Dopamine D3Receptor with the Semliki Forest Virus SystemBiochemical and Biophysical Research Communications, 1996